Ali Rihani

The need for transparency and good practices in the qPCR literature

Stephen A. Bustin, Vladimı́r Beneš, Jeremy A. Garson et al. · Nature Methods · 2013 · 291 citations

Management, Quality Management, Good Laboratory Practice +10

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

Pieter Mestdagh, Erik Fredlund, Filip Pattyn et al. · Oncogene · 2010 · 146 citations

Medicine, Genetics, Molecular Genetics +16

Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53

Tom Van Maerken, Liesbeth Ferdinande, Jasmien Taildeman et al. · JNCI Journal of the National Cancer Institute · 2009 · 120 citations

Medicine, Oncology, Pharmacology +10

miRBase Tracker: keeping track of microRNA annotation changes

Gert Van Peer, Steve Lefever, Jasper Anckaert et al. · Database · 2014 · 88 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

Functional Analysis of the p53 Pathway in Neuroblastoma Cells Using the Small-Molecule MDM2 Antagonist Nutlin-3

Tom Van Maerken, Ali Rihani, Daniel Dreidax et al. · Molecular Cancer Therapeutics · 2011 · 72 citations · Full text

Life Sciences, Molecular Biology, Oncology +17